Skip to main content
Erschienen in: Cancer Chemotherapy and Pharmacology 1/2008

01.01.2008 | Original Article

Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria

verfasst von: N. A. G. Santos, C. S. Catão Bezerra, N. M. Martins, C. Curti, M. L. P. Bianchi, A. C. Santos

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Nephrotoxicity is the major dose-limiting factor of cisplatin chemotherapy. Reactive oxygen species generated in mitochondria are thought to be the main cause of cellular damage in such injury. The present study examined, in vivo, the protective potential of the hydroxyl radical scavenger dimethylthiourea (DMTU) against cisplatin-induced effects on renal mitochondrial bioenergetics, redox state and oxidative stress. Adult male Wistar rats (200 to 220 g) were divided into four groups of eight animals each. The control group was treated only with an intraperitoneal (i.p.) injection of saline solution (1 ml/100 g body weight). The second group was given only DMTU (500 mg/kg body weight, i.p, followed by 125 mg/Kg, i.p., twice a day until they were killed). The third group was given a single injection of cisplatin (10 mg/kg body weight, i.p.). The fourth group was given DMTU (500 mg/kg body weight, i.p.), just before the cisplatin injection (10 mg/kg body weight, i.p.), followed by injections of DMTU (125 mg/kg body weight, i.p.) twice a day until they were killed. Animals were killed 72 h after the treatment. Besides not presenting any direct effect on mitochondria, DMTU substantially inhibited cisplatin-induced mitochondrial injury and cellular death by apoptosis, suppressing the occurrence of acute renal failure. All the following cisplatin-induced effects were prevented by DMTU: (1) increased plasmatic levels of creatinine and blood urea nitrogen (BUN); (2) decreased ATP content, calcium uptake and electrochemical potential; (3) oxidation of lipids, including cardiolipin; and oxidation of proteins, including sulfhydryl, and aconitase enzyme, as well as accumulation of carbonyl proteins; (4) depletion of the antioxidant defense (NADPH and GSH) and (5) increased activity of the apoptosis executioner caspase-3. Our findings show the important role played by mitochondria and hydroxyl radicals in cisplatin-induced nephrotoxicity, as well as the effectiveness of DMTU in preventing the renal mitochondrial damage caused by cisplatin. These results strongly suggest that protection of mitochondria by hydroxyl radical scavengers may be an interesting approach to prevent the kidney tissue damage caused by cisplatin-chemotherapy.
Literatur
1.
Zurück zum Zitat Taguchi T, Nazneen A, Abid MR, Razzaque MS (2005) Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 148:107–121PubMed Taguchi T, Nazneen A, Abid MR, Razzaque MS (2005) Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 148:107–121PubMed
2.
Zurück zum Zitat Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV (1998) In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53:394–401PubMedCrossRef Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV (1998) In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53:394–401PubMedCrossRef
3.
Zurück zum Zitat Ali BH, Al Moundhri MS (2006) Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol 44:1173–1183PubMedCrossRef Ali BH, Al Moundhri MS (2006) Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol 44:1173–1183PubMedCrossRef
4.
Zurück zum Zitat Somani SM, Husain K, Whitworth C, Trammell GL, Malafa M, Rybak LP (2000) Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol 86:234–241PubMedCrossRef Somani SM, Husain K, Whitworth C, Trammell GL, Malafa M, Rybak LP (2000) Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol 86:234–241PubMedCrossRef
5.
Zurück zum Zitat Chang B, Nishikawa M, Sato E, Utsumi K, Inoue M (2002) l-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch Biochem Biophys 405:55–64PubMedCrossRef Chang B, Nishikawa M, Sato E, Utsumi K, Inoue M (2002) l-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch Biochem Biophys 405:55–64PubMedCrossRef
6.
Zurück zum Zitat Matsushima H, Yonemura K, Ohishi K, Hishida A (1998) The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med 131:518–526PubMedCrossRef Matsushima H, Yonemura K, Ohishi K, Hishida A (1998) The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med 131:518–526PubMedCrossRef
7.
Zurück zum Zitat Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335–344PubMedCrossRef Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335–344PubMedCrossRef
8.
Zurück zum Zitat Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius S (2005) Role of mitochondria in toxic oxidative stress. Mol Interv 5:94–111PubMedCrossRef Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius S (2005) Role of mitochondria in toxic oxidative stress. Mol Interv 5:94–111PubMedCrossRef
9.
Zurück zum Zitat Sheu SS, Nauduri D, Anders MW (2006) Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Biophys Acta 1762:256–265PubMed Sheu SS, Nauduri D, Anders MW (2006) Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Biophys Acta 1762:256–265PubMed
10.
Zurück zum Zitat Lamson DW, Brignall MS (1999) Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 4:304–329PubMed Lamson DW, Brignall MS (1999) Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 4:304–329PubMed
11.
Zurück zum Zitat Lamson DW, Brignall MS (2000) Antioxidants and cancer therapy II: quick reference guide. Altern Med Rev 5:152–163PubMed Lamson DW, Brignall MS (2000) Antioxidants and cancer therapy II: quick reference guide. Altern Med Rev 5:152–163PubMed
12.
Zurück zum Zitat Moss RW (2006) Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? Integr Cancer Ther 5:63–82PubMedCrossRef Moss RW (2006) Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? Integr Cancer Ther 5:63–82PubMedCrossRef
13.
Zurück zum Zitat Tsuruya K, Tokumoto M, Ninomiya T, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Hirakata H, Iida K (2003) Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways. Am J Renal Physiol 285:F208–F218 Tsuruya K, Tokumoto M, Ninomiya T, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Hirakata H, Iida K (2003) Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways. Am J Renal Physiol 285:F208–F218
14.
Zurück zum Zitat Cameron NE, Tuck Z, McCabe L, Cotter MA (2001) Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes. Diabetologia 44:1161–1191PubMedCrossRef Cameron NE, Tuck Z, McCabe L, Cotter MA (2001) Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes. Diabetologia 44:1161–1191PubMedCrossRef
15.
Zurück zum Zitat Roychoudhury S, Ghosh SK, Chakraborti T, Chakraborti S (1996) H2O2-induced lipoperoxidation in mitochondria of pulmonary vascular smooth muscle tissue and its modification by DFO, DMTU and DIDS. Indian J Exp Biol 34:1220–1230PubMed Roychoudhury S, Ghosh SK, Chakraborti T, Chakraborti S (1996) H2O2-induced lipoperoxidation in mitochondria of pulmonary vascular smooth muscle tissue and its modification by DFO, DMTU and DIDS. Indian J Exp Biol 34:1220–1230PubMed
16.
Zurück zum Zitat Baek SM, Kwon CH, Kim JH, Jung JS, Kim YK (2003) Differencial roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 142:178–186PubMedCrossRef Baek SM, Kwon CH, Kim JH, Jung JS, Kim YK (2003) Differencial roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 142:178–186PubMedCrossRef
17.
Zurück zum Zitat Berry MN, Edwards AM, Barritt GJ (1991) High-yield preparation of isolated hepatocytes from rat liver. In: Burdon RH, Knippenberg PH (eds) Laboratory techniques in biochemistry and molecular biology. solated hepatocytes preparation, properties and applications. Elsevier, Amsterdam, pp 15–58 Berry MN, Edwards AM, Barritt GJ (1991) High-yield preparation of isolated hepatocytes from rat liver. In: Burdon RH, Knippenberg PH (eds) Laboratory techniques in biochemistry and molecular biology. solated hepatocytes preparation, properties and applications. Elsevier, Amsterdam, pp 15–58
18.
Zurück zum Zitat Pedersen PL, Grenawalt JW, Reynafarje B, Hullihen J, Decker GL, Soper JW, Bustamente E (1978) Preparation and characterization of mitochondria and submitochondrial particles of rat liver-derived tissues. Methods Cell Biol 20:411–481PubMedCrossRef Pedersen PL, Grenawalt JW, Reynafarje B, Hullihen J, Decker GL, Soper JW, Bustamente E (1978) Preparation and characterization of mitochondria and submitochondrial particles of rat liver-derived tissues. Methods Cell Biol 20:411–481PubMedCrossRef
19.
Zurück zum Zitat Santos AC, Uyemura SA, Santos NA, Mingatto FE, Curti C (1997) Hg (II)-induced renal cytotoxicity: in vitro and in vivo implications for the bioenergetic and oxidative status of mitochondria. Mol Cell Biochem 177:53–59PubMedCrossRef Santos AC, Uyemura SA, Santos NA, Mingatto FE, Curti C (1997) Hg (II)-induced renal cytotoxicity: in vitro and in vivo implications for the bioenergetic and oxidative status of mitochondria. Mol Cell Biochem 177:53–59PubMedCrossRef
20.
Zurück zum Zitat O’Connor JE, Vargas JL, Kimler BF, Hernandez-Yago J, Grisolia S (1988) Use of rhodamine 123 to investigate alterations in mitochondrial activity in isolated mouse liver mitochondria. Biochem Biophys Res Commun 151:568–573PubMedCrossRef O’Connor JE, Vargas JL, Kimler BF, Hernandez-Yago J, Grisolia S (1988) Use of rhodamine 123 to investigate alterations in mitochondrial activity in isolated mouse liver mitochondria. Biochem Biophys Res Commun 151:568–573PubMedCrossRef
21.
Zurück zum Zitat Emaus RK, Grunwald R, Lemasters JJ (1986) Rhodamine-123 as a probe of transmembrane potential in isolated rat-liver mitochondria-spectral and metabolic properties. Biochim Biophys Acta 850:436–448PubMedCrossRef Emaus RK, Grunwald R, Lemasters JJ (1986) Rhodamine-123 as a probe of transmembrane potential in isolated rat-liver mitochondria-spectral and metabolic properties. Biochim Biophys Acta 850:436–448PubMedCrossRef
22.
Zurück zum Zitat Scarpa A (1979) Measurements of cation transport with metallochromic indicators. In: Fleisher S, Packer L (eds) Methods in Enzimology. Academic Press, New York, pp 301–352 Scarpa A (1979) Measurements of cation transport with metallochromic indicators. In: Fleisher S, Packer L (eds) Methods in Enzimology. Academic Press, New York, pp 301–352
23.
Zurück zum Zitat Cardoso SM, Pereira C, Oliveira R (1999) Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med 26:3–13PubMedCrossRef Cardoso SM, Pereira C, Oliveira R (1999) Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med 26:3–13PubMedCrossRef
24.
Zurück zum Zitat Masubuchi Y, Suda C, Horie T (2005) Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J Hepatol 42:110–116PubMedCrossRef Masubuchi Y, Suda C, Horie T (2005) Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J Hepatol 42:110–116PubMedCrossRef
25.
Zurück zum Zitat Petit JM, Maftah A, Ratinaud MH, Julien R (1992) 10-N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur J Biochem 209:267–273PubMedCrossRef Petit JM, Maftah A, Ratinaud MH, Julien R (1992) 10-N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur J Biochem 209:267–273PubMedCrossRef
26.
Zurück zum Zitat Gallet PF, Maftah A, Petit JM, Denis-Gay M, Julien R (1995) Direct cardiolipin assay in yeast using the red fluorescence emission of 10-N-nonyl acridine orange. Eur J Biochem 15:113–119CrossRef Gallet PF, Maftah A, Petit JM, Denis-Gay M, Julien R (1995) Direct cardiolipin assay in yeast using the red fluorescence emission of 10-N-nonyl acridine orange. Eur J Biochem 15:113–119CrossRef
27.
Zurück zum Zitat Grattagliano I, Vendemiale G, Sabbá C, Buonamico P, Altomare E (1996) Oxidation of circulating proteins in alcoholics: role of acetaldehyde and xantine oxidase. J Hepatol 25:28–36PubMedCrossRef Grattagliano I, Vendemiale G, Sabbá C, Buonamico P, Altomare E (1996) Oxidation of circulating proteins in alcoholics: role of acetaldehyde and xantine oxidase. J Hepatol 25:28–36PubMedCrossRef
28.
Zurück zum Zitat Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205PubMedCrossRef Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205PubMedCrossRef
29.
Zurück zum Zitat Zheng W, Sean R, Graziano JH (1998) Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res 799:334–342PubMedCrossRef Zheng W, Sean R, Graziano JH (1998) Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res 799:334–342PubMedCrossRef
30.
Zurück zum Zitat Lund BO, Miller DM, Woods JS (1993) Studies on Hg (II)- induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol 45:2017–2024PubMedCrossRef Lund BO, Miller DM, Woods JS (1993) Studies on Hg (II)- induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol 45:2017–2024PubMedCrossRef
31.
Zurück zum Zitat Tietze F (1969) Enzimatic method for quantitative determination of nanogram amounts of total and oxidized gluthathione: applications to mammaliam blood and others tissues. Anal Biochem 27:502–522PubMedCrossRef Tietze F (1969) Enzimatic method for quantitative determination of nanogram amounts of total and oxidized gluthathione: applications to mammaliam blood and others tissues. Anal Biochem 27:502–522PubMedCrossRef
32.
Zurück zum Zitat Singh G (1989) A possible mechanism of cisplatin-induced nephrotoxicity. Toxicology 58:71–80PubMedCrossRef Singh G (1989) A possible mechanism of cisplatin-induced nephrotoxicity. Toxicology 58:71–80PubMedCrossRef
33.
Zurück zum Zitat Sueishi K, Mishima K, Makino K, Itoh Y, Tsuruya K, Hirakata H, Oishi R (2002) Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur J Pharmacol 451:203–208PubMedCrossRef Sueishi K, Mishima K, Makino K, Itoh Y, Tsuruya K, Hirakata H, Oishi R (2002) Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur J Pharmacol 451:203–208PubMedCrossRef
34.
Zurück zum Zitat Kim YH, Kim YW, Oh YJ, Back NI, Chung SA, Chung HG, Jeong TS, Choi MS, Lee KT (2006) Protective effect of the ethanol extract of the roots of Brassica rapa on cisplatin-induced nephrotoxicity in LLC-PK1 cells and rats. Biol Pharm Bull 29:2436–2441PubMedCrossRef Kim YH, Kim YW, Oh YJ, Back NI, Chung SA, Chung HG, Jeong TS, Choi MS, Lee KT (2006) Protective effect of the ethanol extract of the roots of Brassica rapa on cisplatin-induced nephrotoxicity in LLC-PK1 cells and rats. Biol Pharm Bull 29:2436–2441PubMedCrossRef
35.
Zurück zum Zitat Gemba M, Yamaguchi T, Kambara K, Suzuki A, Kawai Y (1992) Increases in urinary enzyme excretion in rats depleted of glutathione inhibited by scavenger of oxygen free radicals. J Pharmacobiodyn 15:513–518PubMed Gemba M, Yamaguchi T, Kambara K, Suzuki A, Kawai Y (1992) Increases in urinary enzyme excretion in rats depleted of glutathione inhibited by scavenger of oxygen free radicals. J Pharmacobiodyn 15:513–518PubMed
36.
Zurück zum Zitat Hanigan MH, Devarajan P (2003) Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 1:47–61PubMed Hanigan MH, Devarajan P (2003) Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 1:47–61PubMed
37.
Zurück zum Zitat Iguchi T, Nishikawa M, Chang B, Muroya O, Sato EF, Nakatani T, Inoue M (2004) Edaravone inhibits acute renal injury and cyst formation in cisplatin-treated rat kidney. Free Radic Res 38:333–341PubMedCrossRef Iguchi T, Nishikawa M, Chang B, Muroya O, Sato EF, Nakatani T, Inoue M (2004) Edaravone inhibits acute renal injury and cyst formation in cisplatin-treated rat kidney. Free Radic Res 38:333–341PubMedCrossRef
38.
Zurück zum Zitat Kharbangar A, Khynriam D, Prasad SB (2000) Effect of cisplatin on mitochondrial protein, glutathione, and succinate dehydrogenase in Dalton lymphoma-bearing mice. Cell Biol Toxicol 16:363–373PubMedCrossRef Kharbangar A, Khynriam D, Prasad SB (2000) Effect of cisplatin on mitochondrial protein, glutathione, and succinate dehydrogenase in Dalton lymphoma-bearing mice. Cell Biol Toxicol 16:363–373PubMedCrossRef
39.
Zurück zum Zitat Hauff KD, Hatch GM (2006) Cardiolipin metabolism and Barth Syndrome. Prog Lipid Res 45:91–101PubMedCrossRef Hauff KD, Hatch GM (2006) Cardiolipin metabolism and Barth Syndrome. Prog Lipid Res 45:91–101PubMedCrossRef
40.
Zurück zum Zitat Antunes LM, Darin JD, Bianchi M de L (2001) Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res 43:145–150PubMedCrossRef Antunes LM, Darin JD, Bianchi M de L (2001) Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res 43:145–150PubMedCrossRef
41.
Zurück zum Zitat Mora L de O, Antunes LM, Francescato HD, Bianchi M de L (2003) The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 47:517–522CrossRef Mora L de O, Antunes LM, Francescato HD, Bianchi M de L (2003) The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 47:517–522CrossRef
42.
Zurück zum Zitat Tirosh O, Katzhendler Y, Barenholz Y, Ginsburg I, Kohen R (1996) Antioxidant properties of amidothionophosphates: novel antioxidant molecules. Free Radic Biol Med 20:421–432PubMedCrossRef Tirosh O, Katzhendler Y, Barenholz Y, Ginsburg I, Kohen R (1996) Antioxidant properties of amidothionophosphates: novel antioxidant molecules. Free Radic Biol Med 20:421–432PubMedCrossRef
43.
Zurück zum Zitat Al-Harbi MM, Osman AM, al-Gharably NM, al-Bekairi AM, al-Shabanah OA, Sabah DM, Raza M (1995) Effect of desferrioxamine on cisplatin-induced nephrotoxicity in normal rats. Chemotherapy 41:448–454PubMedCrossRef Al-Harbi MM, Osman AM, al-Gharably NM, al-Bekairi AM, al-Shabanah OA, Sabah DM, Raza M (1995) Effect of desferrioxamine on cisplatin-induced nephrotoxicity in normal rats. Chemotherapy 41:448–454PubMedCrossRef
44.
Zurück zum Zitat Adwankar M, Banerji A, Ghosh S (1991) Differential response of retinoic acid pretreated human synovial sarcoma cell line to anticancer drugs. Tumori 77:391–394PubMed Adwankar M, Banerji A, Ghosh S (1991) Differential response of retinoic acid pretreated human synovial sarcoma cell line to anticancer drugs. Tumori 77:391–394PubMed
45.
Zurück zum Zitat Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW (1996) Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett 103:183–189PubMedCrossRef Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW (1996) Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett 103:183–189PubMedCrossRef
46.
Zurück zum Zitat Marverti G, Andrews PA (1996) Stimulation of cisdiamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered response in accumulationdefective resistant cells. Clin Cancer Res 2:991–999PubMed Marverti G, Andrews PA (1996) Stimulation of cisdiamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered response in accumulationdefective resistant cells. Clin Cancer Res 2:991–999PubMed
47.
Zurück zum Zitat Hofmann J, Fiebig HH, Winterhalter BR, Berger DP, Grunicke H (1990) Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int J Cancer 45:536–539PubMedCrossRef Hofmann J, Fiebig HH, Winterhalter BR, Berger DP, Grunicke H (1990) Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int J Cancer 45:536–539PubMedCrossRef
48.
Zurück zum Zitat Weijl NI, Cleton FJ, Osanto S (1997) Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 23:209–240PubMedCrossRef Weijl NI, Cleton FJ, Osanto S (1997) Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 23:209–240PubMedCrossRef
49.
Zurück zum Zitat Sastry J, Kellie SJ (2005) Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol 22:441–445PubMedCrossRef Sastry J, Kellie SJ (2005) Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol 22:441–445PubMedCrossRef
50.
Zurück zum Zitat Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307–320PubMedCrossRef Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307–320PubMedCrossRef
51.
Zurück zum Zitat Saillenfait AM, Sabate JP, Langonne I, de Ceaurriz J (1991) Difference in the developmental toxicity of ethylenethiourea and three N,N′-substituted thiourea derivatives in rats. Fundam Appl Toxicol 17:399–408PubMedCrossRef Saillenfait AM, Sabate JP, Langonne I, de Ceaurriz J (1991) Difference in the developmental toxicity of ethylenethiourea and three N,N′-substituted thiourea derivatives in rats. Fundam Appl Toxicol 17:399–408PubMedCrossRef
52.
Zurück zum Zitat Beehler CJ, Ely ME, Rutledge KS, Simchuk ML, Reiss OK, Shanley PF, Repine JE (1994) Toxic effects of dimethylthiourea in rats. J Lab Clin Med 123:73–80PubMed Beehler CJ, Ely ME, Rutledge KS, Simchuk ML, Reiss OK, Shanley PF, Repine JE (1994) Toxic effects of dimethylthiourea in rats. J Lab Clin Med 123:73–80PubMed
53.
Zurück zum Zitat Kim SG, Kim HJ, Yang CH (1999) Thioureas differentially induce rat hepatic microsomal epoxide hydrolase and rGSTA2 irrespective of their oxygen radical scavenging effect: effects on toxicant-induced liver injury. Chem Biol Interact 117:117–134PubMedCrossRef Kim SG, Kim HJ, Yang CH (1999) Thioureas differentially induce rat hepatic microsomal epoxide hydrolase and rGSTA2 irrespective of their oxygen radical scavenging effect: effects on toxicant-induced liver injury. Chem Biol Interact 117:117–134PubMedCrossRef
54.
Zurück zum Zitat Milner LS, Wei SH, Houser MT (1993) Enhancement of renal and hepatic glutathione metabolism by dimethylthiourea. Toxicol Lett 66:117–123PubMedCrossRef Milner LS, Wei SH, Houser MT (1993) Enhancement of renal and hepatic glutathione metabolism by dimethylthiourea. Toxicol Lett 66:117–123PubMedCrossRef
55.
Zurück zum Zitat Otoikhian A, Simoyi RH, Petersen JL (2005) Oxidation of a dimethylthiourea metabolite by iodine and acidified iodate: N,N′-dimethylaminoiminomethanesulfinic acid (1). Chem Res Toxicol 18:1167–1177PubMedCrossRef Otoikhian A, Simoyi RH, Petersen JL (2005) Oxidation of a dimethylthiourea metabolite by iodine and acidified iodate: N,N′-dimethylaminoiminomethanesulfinic acid (1). Chem Res Toxicol 18:1167–1177PubMedCrossRef
Metadaten
Titel
Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria
verfasst von
N. A. G. Santos
C. S. Catão Bezerra
N. M. Martins
C. Curti
M. L. P. Bianchi
A. C. Santos
Publikationsdatum
01.01.2008
Verlag
Springer-Verlag
Erschienen in
Cancer Chemotherapy and Pharmacology / Ausgabe 1/2008
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-007-0459-y

Weitere Artikel der Ausgabe 1/2008

Cancer Chemotherapy and Pharmacology 1/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.